如瑞迪博士 RDY 深沪

交易中 07-08 11:00:24 美东时间

14.445

-0.185

-1.26%

华盛通

立即下载

最高14.475
今开14.385
成交量 30.86万股
最低 14.385
昨收 14.63
总市值 120.28亿
52周最高 15.67
市盈率 ^静 24.82
换手率 0.04%
52周最低 12.185
委比 9.89%
总股本 8.33亿
历史最高 16.8205
量比 0.62
振幅 0.62%
历史最低 4.667
每手 1
风险率 0.52%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

美股夜盘 | Abivax SA Sponsored ADR涨27.41%，航空环境涨19.14%

Abivax SA Sponsored ADR涨27.41%；航空环境涨19.14%；SharonAI Holdings, Inc. Class A涨14.77%

06-30 13:01
美股盘后 | Ares Management Corporation涨5.75%，齐默巴奥米特涨2.31%

Ares Management Corporation涨5.75%；齐默巴奥米特涨2.31%；Krystal Biotech, Inc.涨2.28%

06-19 06:10
美股盘后 | Workday涨12.01%，雅诗兰黛涨9.86%

Workday涨12.01%；雅诗兰黛涨9.86%；Zoom视频通讯涨7.70%

05-22 06:10
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push

Dr. Reddy's launched generic Semaglutide Injection in Canada, expanding its GLP-1 portfolio and strengthening its affordable diabetes treatment presence.

05-17 03:17
Dr Reddy's Laboratories shares are trading lower after the company reported worse-than-expected Q4 financial results.

Dr Reddy's Laboratories shares are trading lower after the company reported wor...

05-12 22:43
Dr Reddy's Laboratories Q4 EPS $0.03 Misses $0.09 Estimate, Sales $821.821M Miss $866.120M Estimate

Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.09 by 66.67 percent. This is a 86.36 percent decrease over earnings of $0.22 per share

05-12 19:42
Earnings Scheduled For May 12, 2026

Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...

05-12 19:11
'Canada Approves Its First Generic Version of Novo's Ozempic' - Bloomberg News

https://www.bloomberg.com/news/articles/2026-04-28/canada-approves-its-first-generic-version-of-novo-s-ozempic

04-29 05:03
美股盘前 | X-Energy, Inc. Class A涨9.08%，高通公司涨4.17%

X-Energy, Inc. Class A涨9.08%；高通公司涨4.17%；如瑞迪博士涨3.95%

04-27 16:10
美股盘前 | 联合租赁涨14.60%，德州仪器涨11.32%

联合租赁涨14.60%；德州仪器涨11.32%；诺基亚涨9.33%

04-23 16:10

派息除权日	每股总股息	派息日期
2026-07-24	0.06
2025-07-25	0.07
2024-07-30	0.41	2024-07-30
2023-07-28	0.41	2023-07-28
2022-08-01	0.32	2022-08-01
2022-07-08	0.32	2022-07-08
2021-07-30	0.28	2021-07-30
2021-07-08	0.28	2021-07-08
2020-07-10	0.27	2020-07-10
2019-07-12	0.27	2019-07-12
2018-07-13	0.27	2018-08-09
2017-07-13	0.29	2017-08-10
2016-07-14	0.28	2016-08-09
2015-07-08	0.29	2015-08-17
2014-08-01	0.27	2014-08-15
2013-07-10	0.23	2013-08-15
2012-06-27	0.23	2012-08-06
2011-06-29	0.23	2011-08-11
2011-06-14	0.64	2011-06-23
2010-06-30	0.22	2010-08-17
2009-07-02	0.11	2009-08-12
2008-07-03	0.07	2008-08-18
2007-07-06	0.07	2007-08-10
2006-07-07	0.11	2006-08-21
2005-07-07	0.11	2005-08-16
2004-07-15	0.11	2004-08-24
2003-08-07	0.11	2003-10-02
2002-08-08	0.05	2002-09-30
2001-11-20	0.10	2001-12-13

公司名称	如瑞迪博士
行业分类	制药
业务描述	Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment refers to the manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

如瑞迪博士 RDY 深 沪

14.445

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

如瑞迪博士 RDY 深沪